---
title: "CONBA released its first-quarter performance, with a net profit attributable to the parent company of 189 million yuan, a year-on-year decrease of 12.34%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237813624.md"
description: "According to the Zhitong Finance APP, CONBA disclosed its first-quarter report for 2025, showing that the company achieved revenue of 1.685 billion yuan, a year-on-year decrease of 7.64%; net profit attributable to the parent company was 189 million yuan, a year-on-year decrease of 12.34%; and net profit excluding non-recurring gains and losses was 162 million yuan, a year-on-year decrease of 19.35%. Basic earnings per share were 0.075 yuan"
datetime: "2025-04-28T09:52:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237813624.md)
  - [en](https://longbridge.com/en/news/237813624.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237813624.md)
generator: "portal-rs"
---

# CONBA released its first-quarter performance, with a net profit attributable to the parent company of 189 million yuan, a year-on-year decrease of 12.34%

According to the Zhitong Finance APP, CONBA (600572.SH) disclosed its first-quarter report for 2025, showing that the company achieved revenue of 1.685 billion yuan, a year-on-year decrease of 7.64%; net profit attributable to shareholders was 189 million yuan, a year-on-year decrease of 12.34%; and net profit excluding non-recurring items was 162 million yuan, a year-on-year decrease of 19.35%. Basic earnings per share were 0.075 yuan

### Related Stocks

- [600572.CN](https://longbridge.com/en/quote/600572.CN.md)

## Related News & Research

- [Definium's LSD-based drug lowers anxiety in second successful late-stage study](https://longbridge.com/en/news/298906879.md)
- [Orexo Announces FDA Acceptance Of Investigational New Drug Application](https://longbridge.com/en/news/298872290.md)
- [Teitur reports positive early data for Parkinson’s peptide TT‑P34](https://longbridge.com/en/news/298896579.md)
- [Phase III ARTEMIS-008 Trial Shows Risvutatug Rezetecan Significantly Improves Overall Survival in Relapsed Small-Cell Lung Cancer](https://longbridge.com/en/news/298830338.md)
- [Skinbetter Science Advances Retinoid Science with New AlphaRet Clinical Findings During National Retinoid Week](https://longbridge.com/en/news/298927118.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**